Studies & Clinical Trials

	Risks & Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Women's Health Initiative (WHI) study in which more than 8,000 women were randomized to receive Prempro (0.625 mg conjugated equine estrogens and 2.5 mg medroxyprogesterone acetate), Jama, 2002
	Warner Study Use of Oral or Subcutaneous (pellet) estradiol 17 beta with natural progesterone in 200 patients followed for 10 years. By Philip O. Warner, MD. Menopause Institute of Los Gatos
	PEPI Bone Mineral Density from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, JAMA, 1995.
	PEPI  Heart Disease Risk Factors from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, JAMA, 1995.
	American Cancer Society's Cancer Prevention Study II: Estrogen replacement therapy and ovarian cancer mortality, JAMA, 2001.

Updated 09/01/2008